Drug Markets/Cefdinir

Cefdinir

24 NDCs across 8 manufacturers|24 Generic,0 Brand

Cefdinir is used to treat bronchitis, escherichia coli infections, haemophilus infections, klebsiella infections, moraxellaceae infections and otitis media, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Dec 4, 1997, and the first generic was approved May 19, 2006. FDA's Orange Book lists 18 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $35 million on Cefdinir across 2.3 million claims for 1.9 million beneficiaries.

Cefdinir is available as 24 NDCs from 8 manufacturers (24 generic, 0 brand), with NADAC prices from $0.11 to $0.12 per MLa 12% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

24

24G / 0B

Manufacturers

8

competing in market

Price Spread

$0.11 – $0.12

per ML, 16 of 24 NDCs

7d Activity

4191 flat

avg -1.0% WoW · of 24 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

24 NDCs total, 24 shown

Drug Price 7d Change
CEFDINIR 300 MG CAPSULE
$0.5003
per EA
CEFDINIR 300 MG CAPSULE
$0.4593
per EA
-0.64%
CEFDINIR 300 MG CAPSULE
$0.4593
per EA
-0.64%
CEFDINIR 300 MG CAPSULE
$0.4593
per EA
-0.64%
CEFDINIR 300 MG CAPSULE
$0.4593
per EA
-0.64%
CEFDINIR 300 MG CAPSULE
$0.4593
per EA
-0.64%
CEFDINIR 300 MG CAPSULE
$0.4593
per EA
-0.64%
CEFDINIR 300 MG CAPSULE
$0.4593
per EA
-0.64%
CEFDINIR 250 MG/5 ML SUSP
$0.1195
per ML
-3.03%
CEFDINIR 250 MG/5 ML SUSP
$0.1195
per ML
-3.03%
CEFDINIR 250 MG/5 ML SUSP
$0.1195
per ML
-3.03%
CEFDINIR 250 MG/5 ML SUSP
$0.1195
per ML
-3.03%
CEFDINIR 250 MG/5 ML SUSP
$0.1135
per ML
-4.42%
CEFDINIR 250 MG/5 ML SUSP
$0.1135
per ML
-4.42%
CEFDINIR 250 MG/5 ML SUSP
$0.1135
per ML
-4.42%
CEFDINIR 250 MG/5 ML SUSP
$0.1135
per ML
-4.42%
CEFDINIR 125 MG/5 ML SUSP
$0.1133
per ML
-0.29%
CEFDINIR 125 MG/5 ML SUSP
$0.1133
per ML
-0.29%
CEFDINIR 125 MG/5 ML SUSP
$0.1133
per ML
-0.29%
CEFDINIR 125 MG/5 ML SUSP
$0.1133
per ML
-0.29%
CEFDINIR 125 MG/5 ML SUSP
$0.1063
per ML
+3.31%
CEFDINIR 125 MG/5 ML SUSP
$0.1063
per ML
+3.31%
CEFDINIR 125 MG/5 ML SUSP
$0.1063
per ML
+3.31%
CEFDINIR 125 MG/5 ML SUSP
$0.1063
per ML
+3.31%

Frequently Asked Questions

What is Cefdinir used to treat?

Cefdinir is used to treat bronchitis, escherichia coli infections, haemophilus infections, klebsiella infections, moraxellaceae infections and otitis media, per the National Library of Medicine's MED-RT classification.

When did Cefdinir become available as a generic?

FDA approved the first generic Cefdinir (ANDA) on May 19, 2006. The Orange Book currently lists 18 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Cefdinir?

In 2024, Medicare Part D spent $35 million on Cefdinir across 2.3 million claims for 1.9 million beneficiaries.

How many Cefdinir products are on the market?

The Cefdinir drug market contains 24 NDCs from 8 manufacturers — 24 generic and 0 brand products.

What is the price range for Cefdinir?

NADAC reference prices for Cefdinir range from $0.1063 to $0.1195 per ML — a 12% difference between cheapest and most expensive. 8 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.

Which manufacturers make Cefdinir?

8 manufacturers list Cefdinir in NADAC. Ranked by number of NDCs, the largest are Ascend Laboratories, LLC (5), Aurobindo Pharma Limited (5), Teva Pharmaceuticals USA Inc. (5), Lupin Pharmaceuticals Inc. (5), Sandoz Inc. (1).

How has the price of Cefdinir changed recently?

Over the past 7 days, 4 Cefdinir NDCs rose and 19 fell, with a market-wide average change of -1.0%.